Evidence against PALB2 involvement in Icelandic breast cancer susceptibility
Open Access
- 17 July 2008
- journal article
- Published by Springer Nature in Journal of Negative Results in BioMedicine
- Vol. 7 (1) , 5
Abstract
Several mutations in the PALB2 gene (partner and localizer of BRCA2) have been associated with an increased risk of breast cancer, including a founder mutation, 1592delT, reported in Finnish breast cancer families. Although most often the risk is moderate, it doesn't exclude families with high-risk mutations to exist and such observations have been reported. To see if high-risk PALB2-mutations may be present in the geographically confined population of Iceland, linkage analysis was done on 111 individuals, thereof 61 breast cancer cases, from 9 high-risk non-BRCA1/BRCA2 breast cancer families, targeting the PALB2 region. Also, screening for the 1592delT founder mutation in the 9 high-risk families and in 638 unselected breast cancer cases was performed. The results indicate no linkage in any of the high-risk families and screening for the 1592delT mutation was negative in all samples. PALB2 appears not to be a significant factor in high-risk breast cancer families in Iceland and the 1592delT mutation is not seen to be associated with breast cancer in Iceland.Keywords
This publication has 20 references indexed in Scilit:
- The emerging landscape of breast cancer susceptibilityNature Genetics, 2007
- Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian womenBreast Cancer Research, 2007
- Breast cancer risk associated with BRCA1 and BRCA2 in diverse populationsNature Reviews Cancer, 2007
- Analysis ofPALB2/FANCN-associated breast cancer familiesProceedings of the National Academy of Sciences, 2007
- A recurrent mutation in PALB2 in Finnish cancer familiesNature, 2007
- Fanconi anemia is associated with a defect in the BRCA2 partner PALB2Nature Genetics, 2006
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancerNature Genetics, 2006
- Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2Molecular Cell, 2006
- A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.Journal of Medical Genetics, 1998